Rare diseases
Investigational molecules
Locations
Back to Italy2 655 clinical trials in Varese, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of AP31969 compared to placebo to control heart rhythm in patients with atrial fibrillation
ItalyStudy of TYRA-300-B01 tablets in patients with low grade, intermediate risk non-muscle invasive bladder cancer who have FGFR3 gene changes
ItalyStudy comparing cetuximab with chemotherapy versus bevacizumab with chemotherapy in patients with advanced colorectal cancer who have wild-type RAS and right-sided tumors
ItalyStudy comparing ALG-000184 with tenofovir disoproxil in untreated adults with chronic hepatitis B virus infection
ItalyStudy of zoldonrasib with daraxonrasib, pembrolizumab and chemotherapy in patients with RAS G12D-mutant non-small cell lung cancer
ItalyStudy of NX-5948 in adults with relapsed or resistant chronic lymphocytic leukemia and small lymphocytic lymphoma who previously received BTK inhibitor and BCL-2 inhibitor treatment
ItalyStudy of efgartigimod given by IV infusion in adolescents aged 12-17 years with chronic immune thrombocytopenia
ItalyItalyStudy of Mezagitamab in Adults with Primary IgA Nephropathy (Berger's Disease) to Reduce Protein in Urine
ItalyStudy of intravenous AOC 1001 to evaluate long-term safety and effectiveness in patients with myotonic dystrophy type 1
ItalyStudy of RO7837195 injection compared to placebo to treat moderate to severe ulcerative colitis
ItalyStudy of amivantamab and pemetrexed for patients with non-small cell lung cancer who have EGFR exon20 insertion mutations and cannot receive platinum therapy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on blood cancers and lymphomas, including studies of novel therapies for acute myeloid leukemia and chronic myeloid leukemia. Clinical trials are evaluating innovative treatment combinations and maintenance strategies.
Investigations include maintenance therapies and comparison of shortened versus standard chemotherapy protocols combined with immunotherapy.
Comprehensive studies on non-small cell lung cancer and pleural mesothelioma, exploring innovative combination therapies and targeted treatments for specific genetic mutations.
Research focuses on personalized treatment approaches and novel drug combinations to improve patient outcomes.
Advanced research in cardiovascular disease and thrombosis, with trials examining innovative treatments for reducing cardiovascular events and managing blood clots.
Studies aim to evaluate new therapeutic approaches for preventing major cardiovascular events and improving patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
